Dr. Jawaher Al-Harthi, a student at Taif University at the University of Sydney in Australia, made a medical discovery that protects against the risk of developing fatty liver disease and complications from Corona (Covid-19), as the research study discovered factors that lead to a high risk of complications of fatty liver disease, with the possibility of targeting these factors. To develop innovative treatments for these diseases. Dr. Jawaher documented her rare research discovery by publishing it in the scientific journal (Nature Communications).
Dr. Al-Harthi explained that the rare medical discovery protects against fatty liver disease, and reduces the complications of the Corona virus (Covid-19) in patients with fatty liver, as she was able, during her study period, to identify pivotal genes, the decrease of which leads to a severe imbalance in body functions, and increased activity. The immune system resulting from an increase in the rate of inflammatory cytokines, confirming that she and the work team succeeded in making a modification that contributes to restoring the gene to its normal level in the cell, stressing that this discovery will make a major leap in the treatment of the aforementioned diseases, and achieve qualitative and new medical success, especially since liver disease Seborrheic disease is one of the most common diseases around the world, affecting about a quarter of the world's population, and the Kingdom and the Arab Gulf countries are among the countries that suffer from high rates of infection.
She said, “The study she conducted concluded that the reason for the increase in deaths among patients with fatty liver infected with the Corona virus is due to a genetic factor, as the ability of the virus appeared to change the genetic makeup of a person, which results in promoting the spread of the disease, and the deterioration of fatty liver patients, in addition to the emergence of diseases and disorders.” Through the recent study, he was able to accurately identify one of the pivotal genes (MBOAT7), whose level is severely reduced in the presence of both fatty liver disease and Covid 19, as its decrease leads to severe disruption in the normal functions of the cells of the human body, and an increase in the immune activity of the resulting cells. This discovery also helped – praise be to God – to protect a fatty liver patient from complications of the Corona virus, such as the longest recovery period.
Okaz (Jeddah)